PRPH — what changed in the latest 10-Q
A section-by-section comparison of PRPH's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-19 vs the prior 10-Q · 2026-06-30
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +12 | −5 | ~21 | 52 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 4 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | Text added/removed | +1 | −1 | 0 | 4 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-19
Interest expense for the three months ended June 30, 2026 was approximately $791,000, compared to $587,000 for the three months ended June 30, 2025. The increase of approximately $204,000 was principally due to the increase of debt discount amortization recognized during the 2026.
Six Months Ended June 30, 2026 as Compared to the Six Months Ended June 30, 2025
For the six months ended June 30, 2026, net revenue was $2.2 million as compared to $2.7 million for the six months ended June 30, 2025. The decrease in revenues was mainly attributable to a decrease in revenues from the sale of consumer products. The Company did not generate any revenues from diagn…
Cost of revenues for the six months ended June 30, 2026 were $1.7 million, which was mainly related to our consumer products. Cost of revenues for the six months ended June 30, 2025 were $1.4 million, comprised of $0.3 million for diagnostic services and $1.1 million for consumer products.
We realized a gross margin of $0.5 million and $1.3 million for the six months ended June 30, 2026 and 2025, respectively. The decrease of $0.8 million was a result of consumer products with different margin product mix. For the six months ended June 30, 2026 and 2025, we realized an overall gross m…
Text removed vs the prior filing · source: 10-Q · 2026-06-30
Interest expense for the three months ended March 31, 2026 was approximately $651,000 as compared to $539,000 million for the three months ended March 31, 2025. The increase in interest expense of $112,000 for the three months ended March 31, 2026 as compared to the three months ended March 31, 2025…
Adjusted EBITDA from continuing operations $(1,621) $(1,614)
(1)We believe that net loss from continuing operations is the financial measure calculated and presented in accordance with GAAP that is most directly comparable to EBITDA and Adjusted EBITDA. EBITDA and Adjusted EBITDA measure the Company’s operating performance without regard to certain expenses. …
(2)The non-cash portion of rent, which reflects the extent to which our GAAP rent expense recognized exceeds (or is less than) our cash rent payments. For newer leases, our rent expense recognized typically exceeds our cash rent payments, while for more mature leases, rent expense recognized is typi…
As of March 31, 2026 and through the date of this filing, the Company has experienced significant liquidity constraints and operating challenges. As of March 31, 2026, the Company had cash on hand of approximately $31,000. The Company has also experienced a significant decline in revenue from its di…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-19
The Company and the Debtors believe the allegations are without merit and intend to defend the matter vigorously. The Company is not aware of any ongoing government investigation relating to the allegations described above.
Text removed vs the prior filing · source: 10-Q · 2026-06-30
The Company believes the allegations are without merit and intends to defend the matter vigorously. The Company is not aware of any ongoing government investigation related to the allegations described above. The Company and the Debtors believe the allegations are without merit and intend to defend …
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice